Erlotinib Hydrochloride | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Erlotinib Hydrochloride
Europe

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Contact Supplier

pharmacompass-1-m-2026-01-12

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-2026-02-09

Erlotinib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 28 USDMF, 2 CEP/COS, 1 JDMF, 15 EU WC, 15 KDMF, 14 NDC API, 28 Listed Suppliers, $ API Reference Price

66 API Suppliers
28 USDMF
2 CEP/COS
1 JDMF
15 EU WC
15 KDMF
14 NDC API
28 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

111 FDF Dossiers, 41 FDA Orange Book, 43 Europe, 10 Canada, 11 South Africa, 6 Listed Dossiers

111 FDF Dossiers
41 FDA Orange Book
43 Europe
10 Canada
11 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

1 SPI Pharma
4 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
5 BASF
10 Corel Pharma Chem
5 DFE Pharma
5 Gangwal Chemicals
4 Ideal Cures
1 Ingredion Pharma Solutions
19 Kerry
2 Keval Exports
3 Kima Chemical
6 Lonza Capsugel
10 Microlex e.U
2 Nitika Pharmaceutical Specialities
1 Novo Excipients
2 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
11 Roquette
6 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
3 Silverline Chemicals
2 The Dow Chemical Company
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 17 Granulation, 15 Controlled & Modified Release, 14 Disintegrants & Superdisintegrants, 14 Direct Compression, 12 Lubricants & Glidants, 10 Thickeners and Stabilizers, 8 Co-Processed Excipients, 6 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 3 API Stability Enhancers, 2 Emulsifying Agents, 2 Rheology Modifiers, 2 Coloring Agents, 1 Topical, 1 Parenteral, 1 Surfactant & Foaming Agents, 1 Solubilizers

39 Coating Systems & Additives
30 Fillers, Diluents & Binders
17 Granulation
15 Controlled & Modified Release
14 Disintegrants & Superdisintegrants
14 Direct Compression
12 Lubricants & Glidants
10 Thickeners and Stabilizers
8 Co-Processed Excipients
6 Film Formers & Plasticizers
6 Taste Masking
5 Empty Capsules
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
3 API Stability Enhancers
2 Emulsifying Agents
2 Rheology Modifiers
2 Coloring Agents
1 Topical
1 Parenteral
1 Surfactant & Foaming Agents
1 Solubilizers

DIGITAL CONTENT

12 News #PharmaBuzz

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 3 Regulatory FDF Prices

6 US Medicaid Prescriptions
3 Regulatory FDF Prices

MARKET PLACE

3 APIs, 1 FDF Dossiers

3 APIs
1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 3,224 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

43 All

01 3CHEPLAPHARM Registration GmbH

02 3Cipla Europe

03 3Krka Dd Novo Mesto

04 1Krka Dd, Novo Mesto

05 3Roche Registration Gmbh

06 3Sandoz A/S

07 3Sandoz Pharmaceuticals Sa

08 3Stada Pharmaceuticals Ag

09 3Sun Pharmaceutical Industries (Europe) Bv

10 3Tarbis Farma Sl

11 6Teva Bv

12 3Teva Pharma Slu

13 3Tillomed Spain Laboratories Sl

14 3Viatris Limited

filter Active Ingredients Reset all filters

43 All

01 39Erlotinib Hydrochloride

02 1Erlotinib hydrochloride

03 3Erlotinibhydroklorid

filter Dosage Form Reset all filters

43 All

01 43Film Coated Tablet

filter Country Reset all filters

43 All

01 18Denmark

02 1Moldova

03 3Norway

04 21Spain

filter Brand Name Reset all filters

43 All

01 3Erlotinib Cipla

02 1Erlotinib Krka

03 3Erlotinib Sandoz

04 3Erlotinib Sun

05 3Erlotinib Tarbis

06 3Erlotinib Teva

07 3Erlotinib Teva Group

08 3Erlotinib Tillomed

09 3Erlotinib "Krka"

10 3Erlotinib "Sandoz"

11 3Erlotinib "Stada"

12 3Erlotinib "Teva B.V."

13 3Erlotinib "Viatris"

14 6Tarceva

List of Suppliers

Product Main Page

01

CHEPLAPHARM Registration GmbH

ASPEN

Not Confirmed

CHEPLAPHARM Registration GmbH

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Marketed

Registration Country : Norway

Erlotinibhydroklorid

Brand Name : Tarceva

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

CHEPLAPHARM Registration GmbH

ASPEN

Not Confirmed

CHEPLAPHARM Registration GmbH

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Marketed

Registration Country : Norway

Erlotinibhydroklorid

Brand Name : Tarceva

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

CHEPLAPHARM Registration GmbH

ASPEN

Not Confirmed

CHEPLAPHARM Registration GmbH

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Marketed

Registration Country : Norway

Erlotinibhydroklorid

Brand Name : Tarceva

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Cipla Europe

ASPEN

Not Confirmed

Cipla Europe

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Cipla

Dosage Form : Film Coated Tablet

Dosage Strength : 25MG

Packaging :

Approval Date : 09-01-2020

Application Number : 84687

Regulatory Info : Cancelled

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Cipla Europe

ASPEN

Not Confirmed

Cipla Europe

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Cipla

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 09-01-2020

Application Number : 84686

Regulatory Info : Cancelled

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Cipla Europe

ASPEN

Not Confirmed

Cipla Europe

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Cipla

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date : 09-01-2020

Application Number : 84685

Regulatory Info : Cancelled

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Krka Dd, Novo Mesto

ASPEN

Not Confirmed

Krka Dd, Novo Mesto

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Moldova

Erlotinib hydrochloride

Brand Name : Erlotinib Krka

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 27-06-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Krka Dd Novo Mesto

ASPEN

Not Confirmed

Krka Dd Novo Mesto

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Denmark

Erlotinib Hydrochloride

Brand Name : Erlotinib \"Krka\"

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 21-02-2020

Application Number : 28106228519

Regulatory Info : Prescription

Registration Country : Denmark

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Krka Dd Novo Mesto

ASPEN

Not Confirmed

Krka Dd Novo Mesto

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Denmark

Erlotinib Hydrochloride

Brand Name : Erlotinib \"Krka\"

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 21-02-2020

Application Number : 28106228619

Regulatory Info : Prescription

Registration Country : Denmark

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Krka Dd Novo Mesto

ASPEN

Not Confirmed

Krka Dd Novo Mesto

ASPEN

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Denmark

Erlotinib Hydrochloride

Brand Name : Erlotinib \"Krka\"

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date : 21-02-2020

Application Number : 28106228419

Regulatory Info : Prescription

Registration Country : Denmark

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.